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Background: GTV delineation is the first crucial step in radiotherapy and requires high accuracy, especially with the
growing use of highly conformal and adaptive radiotherapy techniques. If GTV delineations of observers concord,
they are considered to be of high accuracy.
The aim of the study is to determine the interobserver agreement for GTV delineations of supraglottic laryngeal
carcinoma on CT and on CT combined with MR-images and to determine the effect of adding MR images to
CT-based delineation on the delineated volume and the interobserver agreement.
Methods: Twenty patients with biopsy proven T1-T4 supraglottic laryngeal cancer, treated with curative intent were
included. For all patients a contrast enhanced planning CT and a 1.5-T MRI with gadolinium were acquired in the
same head-and-shoulder mask for fixation as used during treatment. For MRI, a two element surface coil was used
as a receiver coil. Three dedicated observers independently delineated the GTV on CT. After an interval of 2 weeks,
a set of co-registered CT and MR-images was provided to delineate the GTV on CT. Common volumes (C) and
encompassing volumes (E) were calculated and C/E ratios were determined for each pair of observers. The conformity
index general (CIgen) was used to quantify the interobserver agreement. Results: In general, a large variation in
interobserver agreement was found for CT (range: 0.29-0.77) as well as for CT-MR delineations (range: 0.17-0.80). The
mean CIgen for CT (0.61) was larger compared to CT-MR (0.57) (p = 0.032). Mean GTV volume delineated on CT-MR
(6.6 cm3) was larger compared to CT (5.6 cm3) (p = 0.002).
Conclusion: Delineation on CT with co-registered MR-images resulted in a larger mean GTV volume and in a decrease
in interobserver agreement compared to CT only delineation for supraglottic laryngeal carcinoma.
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Radiotherapy for head-and-neck cancer can give rise to se-
vere acute and late side effects [1-4]. To minimize damage
to healthy tissues on one hand and eradicate macroscopic
tumor on the other hand, the gross tumor volume (GTV)
should be determined as accurate as possible. This is
especially required when applying intensity-modulated
radiation therapy (IMRT) and position verification, to
maximize the benefits of high-precision radiation tech-
niques using smaller radiation fields [5].* Correspondence: e.a.jager-3@umcutrecht.nl
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different imaging modalities, to determine the agreement
among observers when delineating the GTV in head-and-
neck cancer. Interobserver agreement and interobserver
variability (disagreement) are often used in the same con-
text whereas these terms express the opposite. Generally,
interobserver agreement is used to assess the quality of an
image modality to visualize the tumor. Thus, when there
is more agreement among the observers, the image
modality is assumed to be more precise and even more
accurate in visualizing the tumor, although high accuracy
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head-and-neck cancer, Computed Tomography (CT) is
the imaging modality of first choice in most cases [11,12].
The advantages of CT are that it is widely available, does
not cause geometrical distortion and has intrinsic infor-
mation on the relative electronical density of the various
tissues used for dose calculation algorithms [11]. Where
CT offers excellent bony detail, magnetic resonance im-
aging (MRI) uses various sequences to visualize soft tissue
and bone contrasts. Especially the capability of MRI to
visualize soft tissues is an improvement compared to CT,
therefore permitting better definition of disease extent
and organs at risk [12-14]. Because MRI does not carry
intrinsic information on electronic density, it is currently
precluded as sole imaging modality in clinical use for
radiotherapy treatment planning in head-and-neck tumors
[11,12]. Various studies demonstrated superior soft tissue
contrast on MRI compared to CT [6,9,15,16]. Although
there is agreement on the capacity of MRI to increase visi-
bility of soft tissue structures in head-and-neck oncology,
there is no agreement on the value of MRI for determin-
ation of the GTV and its influence on the interobserver
agreement [7,8,10,11].
The aim of this study is to compare the interobserver
agreement between delineations on CT and on CT with
co-registered MR-images in supraglottic laryngeal carcin-
oma and to determine the value of adding MR-images to
the “gold standard” CT images.
Methods
Patient selection
Twenty patients with biopsy proven T1-T4 supraglottic
laryngeal cancer (squamous cell carcinoma, SCC) and
treated with high-dose radiotherapy with curative intent
at our institution between November 2005 and October
2009 were included in this study.
From a database of 120 patients with laryngeal and
hypopharyngeal cancer, 39 patients fulfilled the criteria of
inclusion. Which were; patients with a supraglottic tumor,
the availability of a contrast enhanced CT scan and a MRI
with gadolinium performed in a radiotherapy mask.
Twenty patients were randomly selected from this group,
Initial clinical assessment of tumor stage was performed
based on triple-endoscopy under anesthesia, contrast
enhanced CT-scan, and indirect laryngoscopy to assess
mobility of the vocal cords. The study group consisted of
five female and 15 male patients with a mean age of
64 years (range: 40-80 yr).
Imaging technique and data acquisition
CT and MR-imaging was performed prior to radiotherapy
treatment and in radiotherapy position. Patients were
immobilized in a radiotherapy mask (five-point head-and-
shoulder mask, Posicast PR5; Civco, Reeuwijk, TheNetherlands) and received a CT-scan from the base of the
skull to the carina after intravenous injection of iodinated
contrast. The CT-images were obtained by two different
CT-machines. Fifteen patients were scanned with a single
slice Philips Aura machine and five patients with a Philips
Big Bore Brilliance (multi-slice CT). Images were acquired
with helical scans. A slice thickness of 2 mm and 3 mm,
and a pitch of 1.0 (Philips Aura) and 0.7 (Philips Big Bore
Brilliance) was used. Axial images were acquired using a
matrix size of 512 × 512, with a pixel spacing of 0.95 ×
0.95 mm2 - 1.19 × 1.19 mm2. After a mean interval of six
days (range: 0-13 days) the patients underwent a 1.5 Tesla
MRI-scan (Achieva; Philips Medical System, Best, the
Netherlands) in the same fixation device as used for CT-
scanning, combined with a two-element flexible surface coil
[17,18]. For every patient T1-weighted images were obtained
in transversal, sagittal and coronal directions as well as trans-
versal T2-weighted and T1-weighted after injection of gado-
linium according to our clinically used MR protocol for
imaging the larynx and the hypopharynx. A 512 acquisition
and reconstruction matrix was used. The field-of-view diam-
eter was 210 mm and the slice thickness was 3 mm. An
example of the acquired MR-images is shown in Figure 1.
The registration was performed by a medical physicist who
defined a rectangular box containing the GTV and surround-
ing bony structures. The rigid registration was performed
using the mutual information algorithm within this box and
the registration was visually controlled. This procedure is ac-
cording to clinical practice at our department. No approval
of an ethics committee was needed according to Dutch law.
Delineation of GTV
Gross tumor volume (GTV) was defined as the macro-
scopic (gross) extent of the primary tumor that is demon-
strable on the imaging modality e.g, MRI-scan, CT-scan.
The following guidelines for delineation of the GTV were
agreed upon by the three observers at a consensus meet-
ing in advance of the delineations sessions. Areas of doubt
had to be included in the GTV according to radiotherapy
practice. Edema around the tumor had to be included and
evident stasis of saliva had to be excluded in the delinea-
tion. Criteria for soft tissue infiltration were: left-right
asymmetry, contrast enhancement and fatty space infiltra-
tion. For cartilage invasion on CT the following signs were
used: osteolysis of dense mineralized areas (if in contact
with the primary tumor), cortical erosions, abnormal
increased asymmetrical density and presence of tumor on
both sides of bony/cartilaginous structures. Sclerotic
cartilage with an intact cortex was not to be included in
the GTV. Guidelines for interpretation of neoplastic inva-
sion of laryngeal cartilages, as defined by M. Becker et al.
[19], were used during delineation on MRI.
Three dedicated and MRI-trained head-and-neck spe-
cialists (two radiation oncologists and one radiologist)
Figure 1 MR-images of the larynx acquired in a radiotherapy mask. a:T1-weighted sagittal view, b: T1-weighted coronal view. Transversal
views: c: T2-weighted, d: T1-weighted, e: T1-weighted + gadolinium.
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delineated the GTV. They started with CT-images at fixed
window/level 350/50 with minor adjustments of 10-20
HU based on individual preferences.
After an interval of more than two weeks, to avoid pos-
sible bias due to recall of the previous delineation, the
same CT (without previous contours) was delineated with
the co-registered MR-images (T1w, T1w +Gd, T2w)
simultaneously visible. Typical examples of delineations
on CT and CT-MR can be found in the Additional files 1,
2, 3 and 4.
The observers received an anonymised triple-endoscopy
report and were instructed to record: delineation time,
window/level and which anatomical parts of the larynx
were involved by tumor, during delineating on CT and
CT-MR. Observers were also asked to subjectively rate
image quality (good, moderate, poor and not assessable)
and tumor detectability [20]. The latter was scored asfollowed; 0, if tumor boundaries were not visible, 1: tumor
is visible, boundaries not, 2: boundaries are visible but not
clear, 3: tumors as well as boundaries are clearly visible.
Volumetric analysis and interobserver agreement
All GTVs were delineated in volume tool [21], a software
application that is capable of simultaneous visualization of
multiple 3-dimensional datasets. The volume of the GTV
was determined by multiplying the number of voxels
contained within a contour by the size of the voxel. The
size of the voxel depends on the resolution of the image
reconstruction and the slice thickness. If the center of the
voxel is within the contour boundary, the voxel is
regarded as being part of the volume.
For each pair of observers, the common volume (C; the
volume that is part of both GTVs of one patient) and the
encompassing volume (E; volume encompassing both
GTVs of one patient) of the delineated GTVs for each
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coefficient) were determined for each pair of observers
(observer a&b, a&c, b&c). The Jaccard coefficient can only
be used as a conformity index for a situation in which two
delineated volumes are compared. Therefore we used the
conformity index general (CIgen) to quantify the agree-
ment between all observers. This index is independent of
the number of observers or delineated volumes [22].
CIgen is defined as the sum of the common volumes of
the various observer pairs divided by the sum of the
encompassing volumes of these pairs and is written for
the 3 observers as the following formula:
CIgen ¼ a∩bð Þ þ a∩cð Þ þ b∩cð Þa∪bð Þ þ a∪cð Þ þ b∪cð Þ
A CIgen of 1.00 indicates perfect overlap (identical de-
lineations), whereas a CIgen of 0.00 indicates no overlap
at all.
Clinical impact
Since the GTV is extended using margins to correct for
several factors such as microscopic disease, movement
and setup inaccuracies, the planning target volume is
considerably larger than the GTV.
For each patient the GTV delineations were extended
with a margin to create a PTV. Two scenarios were inves-
tigated according to the work of Vugts et al. [23]. In one
scenario conventional margins were applied (PTVclinical).
In the other scenario tight margins were investigated
(PTVtight). A margin of 8 mm was used for PTVtight and15
mm for PTVclinical. As a “worst case scenario”, the largest
GTV was assumed to be the correct GTV. Subsequently,
it was determined in how many cases this GTV was not
covered by the PTVs.
Statistical analysis
Based on non-normality of the samples according to the
Shapiro Wilk test, the Wilcoxon signed-rank test was
applied for statistical comparison of the mean delineated
volume (GTV) between CT and CT-MR.
The coefficient of variation (COV), defined as COV=
standard deviation (SD)/mean volume, was determined
for all delineated GTVs of the patients for each imaging
modality. For each modality correlation between mean
GTV volume and COV was measured using a Spearman
rank correlation test.
A Student paired t-test was used for the comparison of
the CIgen on CT and CIgen on CT-MR. These samples
were both normally distributed according to the Shapiro
Wilk test. For each modality the correlation between
CIgen and GTV volume was measured using a Spearman
rank correlation test. Statistical analyses were performed
with SPSS 16.0 using a (alpha) level of significance of 0.05.Results
Image quality was considered “good” for the majority of
the CT-images as well as for MR-images. For some pa-
tients the image quality of the CT-scan was deteriorated
by contrast insufficiency or due to swallowing. Movement
due to swallowing had an adverse effect on MR-image
quality. However, the image quality was never considered
to be “not assessable”, nor did the observers unanimously
qualify the image quality as being “poor”.
For the CT of 16 patients, at least one observer re-
corded that the tumor borders were “visible but not clear”
or worse (grade 2, 1 and 0). For MRI, this was the case for
11 patients. In eight patients at least one of the observers
recorded explicit difficulties in the cranial and/or caudal
direction on CT and in four patients referring to the MRI.
These recorded difficulties in cranial and caudal direction
were objectified by larger discrepancies (smaller common
volumes) in the delineations in the cranial and caudal
areas and in de region of the epiglottis for CT as well as
for MRI in nearly all patients.Volumetric analysis
The difference between GTV volume on CT and on
CT-MR was considerably larger in two cases (patient 10
and 15) (Table 1) compared to the difference for the
remaining patients.
The median GTV volume of the three observers on CT-
MR (median: 6.6 cm3, interquartile range: 2.9-9.2, 95%
confidence interval: 4.8-11.8 cm3) was significantly larger
(p = 0.002) compared to median of the GTV volume on
CT (median: 5.6 cm3, interquartile range: 2.5-7.9, 95%
confidence interval: 4.2-9.8 cm3) (Table 1).
A large variation in COV was found between the GTV
per modality as well as between the modalities (Table 1).
The mean COV on CT (0.17, SD 0.12) was comparable
to CT-MR (0.19, SD 0.16) (Table 1).
No relation between COV and the mean GTV volume
for any of the imaging modalities was observed (CT:
rho = -0.28 p = 0.23 CT-MR: rho = 0.05 p = 0.84).Interobserver agreement
In general, a large variation in interobserver agreement
was found for the delineated tumors on CT as well as
for CT-MR delineations (Table 1, Figures 2 and 3).
The mean CIgen for CT was significantly larger (0.61,
SD 0.12, range 0.29-0.77, 95% confidence interval: 0.56-
0.67) compared to CT-MR (0.57, SD 0.15, range 0.17-0.80,
95% confidence interval: 0.50-0.64) (p = 0.032).
Although the smallest CIgens were observed for the
smallest tumors (Table 1), no relation between CIgen and
the mean GTV volume for CT as well as for CT-MR de-
lineations was observed (CT: rho = 0.28 p = 0.24, CT-MR:
rho = 0.31 p = 0.18).
Table 1 Gross tumor volumes delineated by 3 observers on CT and CT-MR in supraglottic laryngeal carcinoma
Patient (no.) Tumor stage Mean GTV (cm3) CIgen COV
CT CT-MR CT CT-MR CT CT-MR
8 T1 1.2 1.3 0.52 0.54 0.23 0.11
6 T2 1.5 1.9 0.29 0.32 0.41 0.66
12 T3 1.6 1.5 0.62 0.67 0.18 0.03
16 T3 1.9 2.8 0.43 0.17 0.38 0.13
20 T2 2.3 2.8 0.61 0.41 0.14 0.38
14 T2 2.9 3.2 0.73 0.68 0.07 0.05
9 T2 5.0 5.1 0.65 0.61 0.17 0.25
4 T2 5.3 5.2 0.62 0.50 0.19 0.41
1 T3 5.5 6.7 0.76 0.66 0.04 0.06
19 T2 5.5 6.6 0.63 0.54 0.04 0.06
5 T2 5.7 6.7 0.49 0.49 0.32 0.30
11 T2 6.8 6.5 0.68 0.69 0.18 0.14
13 T2 7.0 6.8 0.77 0.80 0.10 0.03
7 T2 7.1 7.3 0.75 0.73 0.04 0.12
2 T3 7.9 9.6 0.70 0.59 0.09 0.27
18 T3 7.9 8.1 0.59 0.57 0.10 0.08
17 T3 11.1 11.8 0.67 0.62 0.05 0.15
10 T4 12.8 22.1 0.49 0.50 0.36 0.35
15 T4 14.7 20.6 0.69 0.68 0.09 0.16
3 T3 27.0 29.1 0.60 0.66 0.26 0.11
Tumor stage, mean delineated tumor volumes (GTV) in cm3 of 3 observers ranked by mean GTV. COV (coefficient of variation) and CIgen (conformity index
general) for GTV on CT and CT-MR.
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When applying tight margins, for 12 of the 20 patients the
largest GTV contour was not covered by all the PTVs.
When using clinical margins this number decreased to
two of the 20 patients. The anatomical sites where the
GTV contour was not encompassed by the PTV contours
were mostly in cranial and caudal direction.
Discussion
The present study on supraglottic laryngeal carcinoma
demonstrates that adding MR-images to CT resulted in a
decrease in interobserver agreement compared to the in-
terobserver agreement of the CT-only delineation-session.
Furthermore, the median GTV volume was larger on CT-
MR compared to CT although there was no relation found
between the GTV volume and the CIgen. Subjectively, the
observers reported an increased visibility of anatomical
details on MRI.
According to other studies based on head-and-neck
cancer where MRI was compared with CT, Ahmed et al.
[6] demonstrated that the delineated GTV volume for
base of tongue tumors on MRI was almost two times
larger compared to CT. They also reported a superior
subjective visualization and delineation of base of tongue
tumors on the MRI-scans relative to CT. Several otherstudies concluded the same for tongue and floor of the
mouth cancer [15,16] and nasopharyngeal carcinoma [9].
Although there is agreement on the capacity of MRI
to increase visibility in head-and-neck oncology, there is
no agreement on the value of MRI for determination of
the GTV. Rasch et al. [10] showed better interobserver
agreement with matched CT-MRI, for target delineation
in nasopharynx cancer compared to CT alone. A large
improving factor on the interobserver agreement was
the decision to include entire anatomical structures
invaded by tumor. A previous study done by Rasch et al.
[7] reported that for six patients with advanced head-
and-neck carcinoma, the delineated GTVs and interob-
server agreement was better for delineations on MRI (with
CT-images available) than on CT (with MR-images avail-
able). However, no difference between one single ob-
servers’ mean GTV volume delineated on CT and on MRI
for oropharyngeal, laryngeal and hypopharyngeal tumors
was found by Daisne et al. [11]. Additionally, a study
performed by Geets et al. [8] showed no clinical advantage
of MRI over CT in terms of volume determination and
interobserver agreement for pharyngo-laryngeal tumors.
Concerning the design of the study, this study [8] was the
only one that, to some extent, resembled ours. However,
we were not able to adequately compare our findings with
Figure 2 Delineations of three observers on contrast enhanced CT and CT-MR. Delineations of three observers on contrast enhanced CT
(a, c, e) and CT-MR (b, d, f) (T1-weighted). Transversal (a, b), sagittal (c, d) and coronal (e, f) views.
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without CT for delineating. Furthermore, the use of a dif-
ferent metric to quantify the interobserver agreement,
based on area of overlap between contours, hampers a de-
tailed comparison. In general, a wide variety of metrics is
used to quantify the interobserver agreement in delineation
studies for example: Dice similarity coefficient, common to
encompassing volume ratio and Jaccard index [22,24,25].
Since the GTV is extended by margins to correct for
several factors such as microscopic disease, movement
and setup inaccuracies, the PTV is larger than the GTV.
Our analysis indicates that large conventional margins
partly compensate for the interobserver variation. How-
ever, when evidence-based tight margins are applied theinterobserver variation for delineating the GTV might
result in inadequate dose coverage of the GTV.
Tumor recurrence was diagnosed for two patients in
this study. Due to the development in radiotherapy treat-
ment schedules and tumor treatment planning between
2005 and 2009 we are not able to draw conclusions from
this finding concerning treatment outcomes. Furthermore,
the treatment plan was based on the delineation from the
treating radiation-oncologist while the delineations in this
study were used for research purposes.
In our study a dedicated MR protocol for radiotherapy
GTV delineation was applied. This protocol has been used
at our department since 2005. Care was taken to optimize
the MR-image quality for radiotherapy purposes [17]. For
Figure 3 Delineations of three observers on contrast enhanced CT and CT-MR. Delineations of three observers on contrast enhanced CT
(a, c, e, g) and on CT-MR (b, d, f, h) (T1-weighted + Gd) for four different patients.
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sidered “good”. However, the introduction of 3.0 Tesla
and recently 7.0 Tesla MRI scanners and the development
of new fast scan protocols might further optimize MR
image quality.
A shortcoming of the studies of Daisne [11] and Geets
[8] was the use of a multipurpose bodycoil as receiver coil
for MR-imaging. Rasch [7] used a head coil for MR-
imaging only without a mask or external markers, causing
a decrease in image quality.
Although, in our study, the observers reported a subject-
ively increased visibility of anatomical details on MRI
compared to CT, this did not improve agreement between
observers. On the contrary, interobserver agreement was
decreased. Apparently, additional MRI information
resulted in more options to interpret the imaging data,
resulting in a greater variation in delineations and an in-
crease in delineated volumes. The inclusion of areas of
doubt in the GTV, as described in our delineation guide-
lines, further increased these variations and volumes. In
our opinion, the increased visibility of anatomical detailson MRI might be of value in radiotherapy practice when it
is clear how to combine the information of different MR-
sequences when delineating the GTV. To maximize the
benefits of high-precision radiation techniques, the gross
tumor volume (GTV) should be determined as accurate
as possible. Clear guidelines for interpretation and GTV
delineation of laryngeal carcinoma could therefore be very
useful. To develop these guidelines, a validation-study
with total laryngectomy specimens is currently being
performed at our institution. In that study, tumor tissue is
identified based on pathological findings and compared
with GTV delineations on different image modalities [26].
The large variation in interobserver agreement for the
GTVs delineated on CT as well as for CT-MR delineations
(Table 1) suggests that for some tumors it was more diffi-
cult to delineate the GTV compared to others. In some
cases, this might have been influenced by a moderately
decreased image quality. In our opinion, this variation was
mostly caused by differences in location and character-
istics of the tumor, and difficulties to distinguish tumor
borders.
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the delineated volumes on CT and CT-MR were the
largest. This might be explained by the presence of edema
that is increased in larger tumors and which could cause
an increase in delineated volume on CT-MR since MR is
superior in visualizing soft tissues (e.g. edema) [12-14].
The observers also included more cartilage in their GTV
on CT-MR compared to CT only. Besides the capacity of
MRI to increase visibility of soft tissue, MRI might have
an improved visibility for cartilage invasion compared to
CT. Research performed by Becker et al. supports this
presumption [14,19]. Since there was no histopathological
data available for this study we are not able to further
investigate this finding.
The CT-images used in this study were obtained on 2
different CT-scanners and slice thickness varied between
2 and 3 mm. This did not influence the results since there
were no remarkable differences between the CIgens com-
paring the two scanners. Besides, no difference in image
quality and no specific matching related problems were
reported.
Conclusions
The interobserver agreement was decreased in the CT-
MR session compared to the CT only delineations and
mean delineated volume on CT-MR was larger compared
to CT. At this point MR has no objective added value con-
cerning the CIgen outcomes. The increased visualization
of anatomical details on MRI might lead to an increased
interobserver agreement and more accurate GTV estima-
tion only when clear guidelines for interpretation and
delineation of MR-images of laryngeal tumors are present.
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Additional file 1: Delineations of three observers on CT for patient 2.
Delineations of three observers on contrast enhanced CT for patient
number 2. From left to right: transversal, sagittal en coronal views.
Additional file 2: Delineations of three observers on CT-MR for
patient 2. Delineations of three observers on for the CT-MR session for
patient 2. Delineations were performed on the contrast enhanced CT
with co-registered MR simultaneously visible (CT images are not shown).
Upper left: transversal T1-weighed view. Lower left: transversal
T1-weighted + gadolinium view. Upper right: coronal T1-weighted
view. Lower right: sagittal T1-weighted view.
Additional file 3: Delineations of three observers on CT for patient 11.
Delineations of three observers on contrast enhanced CT for patient
number 11. From left to right: transversal, sagittal en coronal views.
Additional file 4: Delineations of three observers on CT-MR for
patient 11. Delineations of three observers on for the CT-MR session for
patient 11. Delineations were performed on the contrast enhanced CT
with co-registered MR simultaneously visible (CT images are not shown).
Upper left: transversal T1-weighed view. Lower left: transversal
T1-weighted + gadolinium view. Upper right: coronal T1-weighted
view. Lower right: sagittal T1-weighted view.
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